Market Cap (In INR)
1.43 Billion
Revenue (In INR)
1.27 Billion
Net Income (In INR)
35.9 Million
Avg. Volume
7594.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 65.1-699.75
- PE
- -
- EPS
- -
- Beta Value
- 1.6330068
- ISIN
- INE172E01011
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- -
- Employee Count
- -
- Website
- http://www.smruthiorganics.com
- Ipo Date
- 2005-06-16
- Details
- Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. Its products include amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. The company was founded by Purushotham Mallayya Eaga on July 11, 1989 and is headquartered in Solapur, India.
More Stocks
-
5425
-
XPROINDIAXpro India Limited
XPROINDIA
-
CHGCF
-
SDMHF
-
2601
-
RKHNFRockhaven Resources Ltd.
RKHNF
-
IMAGICAAImagicaaworld Entertainment Limited
IMAGICAA
-
0054